tm logo

Monitor this mark

View On USPTO

XIGDUO
Live/Registered
REGISTERED AND RENEWED

on 08 Jul 2024

Last Applicant/ Owned by

Astrazeneca AB

Astraallén

Södertälje

SE

SE-15185

Serial Number

85532391 filed on 02th Feb 2012

Registration Number

4708578 registered on 24th Mar 2015

in the Principal Register

Correspondent Address

Cara M. Kearney

Cara M. Kearney AstraZeneca Pharmaceuticals LP

Wilmington, DE 19850-5437

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XIGDUO

Pharmaceutical preparations for human use for the treatment or prevention of metabolic disorders, namely, diabetes

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment or prevention of metabolic disorders, namely, diabetes

First Use Date in General

14th Nov 2014

First Use Date in Commerce

14th Nov 2014

Mark Details

Serial Number

No 85532391

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
08th Jul 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08th Jul 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08th Jul 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08th Jul 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09th Apr 2024TEAS SECTION 8 & 9 RECEIVED
24th Mar 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
22nd Jul 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
22nd Jul 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
22nd Jul 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Jul 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED